The genomic map of breast cancer: which roads lead to better targeted therapies?
about
Outsmarting cancer: the power of hybrid genomic/proteomic biomarkers to predict drug response.The dynamic range of circulating tumor DNA in metastatic breast cancerA phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.Theranostic Gold Nanoantennas for Simultaneous Multiplexed Raman Imaging of Immunomarkers and Photothermal Therapy
P2860
The genomic map of breast cancer: which roads lead to better targeted therapies?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The genomic map of breast cancer: which roads lead to better targeted therapies?
@en
The genomic map of breast cancer: which roads lead to better targeted therapies?
@nl
type
label
The genomic map of breast cancer: which roads lead to better targeted therapies?
@en
The genomic map of breast cancer: which roads lead to better targeted therapies?
@nl
prefLabel
The genomic map of breast cancer: which roads lead to better targeted therapies?
@en
The genomic map of breast cancer: which roads lead to better targeted therapies?
@nl
P2860
P356
P1476
The genomic map of breast cancer: which roads lead to better targeted therapies?
@en
P2093
Carlos L Arteaga
Thomas P Stricker
P2860
P2888
P356
10.1186/BCR3435
P577
2013-01-01T00:00:00Z
P5875
P6179
1042703009